Gilead Stock Rises on COVID-19 Treatment Price

Analysts are divided on GILD

Deputy Editor
Jun 29, 2020 at 10:22 AM
facebook X logo linkedin


Gilead Sciences, Inc. (NASDAQ:GILD) announced pricing for its coronavirus treatment remdesivir. The drugmaker said it will sell remdesivir to the governments of developed countries for $390 per vial, while the price for private insurance companies in the U.S. will be $520 per vial -- meaning lower prices for government programs like Medicare versus a higher price for privately insured patients. Typically, six vials of remdesivir are used per five-day treatment, meaning it will cost a total of $2,340 for one course. Currently, the shares of GILD are up 1.6% to trade at $75.76.

Longer-term, GILD now sports a year-over-year lead of 11.2%. The equity has had a volatile run on the charts, since May, consolidating between the $72-$79 levels, with its 120-day moving average sitting just below to contain any sharp pullbacks.

Digging deeper, GILD's Schaeffer's Volatility Index (SVI) of 36% sits in the low 22nd annual percentile of all other readings from the past year, implying that options can be had for a bargain right now. Plus, the equity's Schaeffer's Volatility Scorecard (SVS) sits at an extremely low 5, meaning Gilead stock has failed to exceed option traders' volatility expectations during the past year.  

Analysts, meanwhile, are divided regarding GILD. Of the 21 in coverage, seven call it a "buy" or better. Meanwhile, 13 call it a "hold," and just one says its a "strong sell." Meanwhile, the 12-month consensus price target of $80.58 is an 8.1% premium to current levels.

 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI